We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » OIG: Many FDAers Still Wary to Air Concerns, Unclear on Dispute Process
OIG: Many FDAers Still Wary to Air Concerns, Unclear on Dispute Process
June 8, 2012
The number of internal scientific disagreements over device approvals has waned since late 2009, when the FDA implemented new procedures for handling such disputes, but many employees are still hesitant to raise scientific concerns with agency management, according to a new report by the HHS Office of Inspector General.